drugset

drugset / Trial / NCT01632137

Efficacy and Safety of Rebamipide in Subjects With Dry Eye Syndrome

NCT01632137 ↗

Phase 3 Completed 564 enrolled Kubota Vision Inc. Otsuka Pharmaceutical Co., Ltd. · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of rebamipide ophthalmic suspension in subjects with dry eye syndrome.

Timeline

Start: 2012-06
Primary completion: 2013-06
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rebamipide	Small molecule	2 %	Topical

Indications